Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Biol Chem ; 288(36): 25956-25963, 2013 Sep 06.
Artigo em Inglês | MEDLINE | ID: mdl-23884416

RESUMO

Heparan sulfate (HS) proteoglycans, present at the plasma membrane of vascular endothelial cells, bind to the angiogenic growth factor VEGFA to modulate its signaling through VEGFR2. The interactions between VEGFA and proteoglycan co-receptors require sulfated domains in the HS chains. To date, it is essentially unknown how the formation of sulfated protein-binding domains in HS can be regulated by microRNAs. In the present study, we show that microRNA-24 (miR-24) targets NDST1 to reduce HS sulfation and thereby the binding affinity of HS for VEGFA. Elevated levels of miR-24 also resulted in reduced levels of VEGFR2 and blunted VEGFA signaling. Similarly, suppression of NDST1 using siRNA led to a reduction in VEGFR2 expression. Consequently, not only VEGFA binding, but also VEGFR2 protein expression is dependent on NDST1 function. Furthermore, overexpression of miR-24, or siRNA-mediated reduction of NDST1, reduced endothelial cell chemotaxis in response to VEGFA. These findings establish NDST1 as a target of miR-24 and demonstrate how such NDST1 suppression in endothelial cells results in reduced responsiveness to VEGFA.


Assuntos
Regulação Enzimológica da Expressão Gênica/fisiologia , Heparitina Sulfato/metabolismo , Células Endoteliais da Veia Umbilical Humana/metabolismo , MicroRNAs/metabolismo , Sulfotransferases/biossíntese , Fator A de Crescimento do Endotélio Vascular/metabolismo , Quimiotaxia/fisiologia , Heparitina Sulfato/genética , Células Endoteliais da Veia Umbilical Humana/citologia , Humanos , MicroRNAs/genética , Sulfotransferases/genética , Fator A de Crescimento do Endotélio Vascular/genética , Receptor 2 de Fatores de Crescimento do Endotélio Vascular/genética , Receptor 2 de Fatores de Crescimento do Endotélio Vascular/metabolismo
2.
J Biol Chem ; 287(40): 33905-16, 2012 Sep 28.
Artigo em Inglês | MEDLINE | ID: mdl-22869369

RESUMO

The present study addresses the roles of heparan sulfate (HS) proteoglycans and chondroitin sulfate (CS) proteoglycans in the development of zebrafish pharyngeal cartilage structures. uxs1 and b3gat3 mutants, predicted to have impaired biosynthesis of both HS and CS because of defective formation of the common proteoglycan linkage tetrasaccharide were analyzed along with ext2 and extl3 mutants, predicted to have defective HS polymerization. Notably, the effects on HS and CS biosynthesis in the respective mutant strains were shown to differ from what had been hypothesized. In uxs1 and b3gat3 mutant larvae, biosynthesis of CS was shown to be virtually abolished, whereas these mutants still were capable of synthesizing 50% of the HS produced in control larvae. extl3 and ext2 mutants on the other hand were shown to synthesize reduced amounts of hypersulfated HS. Further, extl3 mutants produced higher levels of CS than control larvae, whereas morpholino-mediated suppression of csgalnact1/csgalnact2 resulted in increased HS biosynthesis. Thus, the balance of the Extl3 and Csgalnact1/Csgalnact2 proteins influences the HS/CS ratio. A characterization of the pharyngeal cartilage element morphologies in the single mutant strains, as well as in ext2;uxs1 double mutants, was conducted. A correlation between HS and CS production and phenotypes was found, such that impaired HS biosynthesis was shown to affect chondrocyte intercalation, whereas impaired CS biosynthesis inhibited formation of the extracellular matrix surrounding chondrocytes.


Assuntos
Cartilagem/metabolismo , Sulfatos de Condroitina/química , Regulação da Expressão Gênica no Desenvolvimento , Heparitina Sulfato/química , Alelos , Animais , Cruzamentos Genéticos , Progressão da Doença , Feminino , Genótipo , Masculino , Microscopia Confocal/métodos , Microscopia Eletrônica de Transmissão/métodos , Modelos Biológicos , Morfogênese , Mutação , Faringe/patologia , Peixe-Zebra
3.
Biochemistry ; 48(5): 1094-8, 2009 Feb 10.
Artigo em Inglês | MEDLINE | ID: mdl-19140680

RESUMO

Protein C inhibitor (PCI) is a versatile serine protease inhibitor with both pro- and anticoagulant and other properties. Interactions of certain ligands with PCI, including heparin, affect its specificity for proteases. In this study, heparin was found to enhance PCI inhibition of factor Xa up to 42-fold in the presence of a physiological Ca(2+) concentration, whereas no heparin-induced activation was observed in the absence of Ca(2+). These results thus show that factor Xa adds to the group of proteases whose inhibition by PCI is enhanced by heparin and that such inhibition contributes to the anticoagulant properties of PCI by a Ca(2+)-dependent mechanism.


Assuntos
Cálcio/fisiologia , Inibidores do Fator Xa , Heparina/fisiologia , Inibidor da Proteína C/fisiologia , Sítios de Ligação , Cálcio/química , Cátions Bivalentes/química , Fator Xa/metabolismo , Heparina/química , Humanos , Cinética , Inibidor da Proteína C/química , Espectrofotometria
4.
J Histochem Cytochem ; 60(12): 936-42, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22899864

RESUMO

Proteoglycans, with their core proteins and attached glycosaminoglycan chains, are recognized as important partners in many biological processes, yet often experimental analysis of their molecular action is considered for only part of these molecules: either the protein or the carbohydrate unit. In this article, we have tried to summarize, with an example of the syndecan family in general and more specifically with syndecan-1, what is known considering the mutual influence of these different components, and we follow whether the nature of the glycosaminoglycan chains matters for these effects.


Assuntos
Glicosaminoglicanos/metabolismo , Sindecana-1/metabolismo , Animais , Proteoglicanas de Sulfatos de Condroitina/metabolismo , Desenvolvimento Embrionário , Transição Epitelial-Mesenquimal , Glicosaminoglicanos/química , Glicosilação , Proteoglicanas de Heparan Sulfato/metabolismo , Humanos , Neoplasias/metabolismo , Neoplasias/patologia , Sindecana-1/química
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa